Neutralizing Monoclonal Antibody for Mild to Moderate COVID-19. | JAMA;325(7): 644-645, 2021 02 16. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Neutralizing Monoclonal Antibody for Mild to Moderate COVID-19.

Malani, Preeti N; Golub, Robert M.

Malani PN; Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor.
Golub RM; Associate Editor, JAMA.

JAMA ; 325(7): 644-645, 2021 02 16.

Article in English | MEDLINE | ID: covidwho-1126321

Subject(s)

Antibodies, Monoclonal; COVID-19; Antibodies, Neutralizing; Antibodies, Viral; Humans; SARS-CoV-2; Viral Load

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Antibodies, Monoclonal Limits: Humans Language: English Journal: JAMA Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Antibodies, Monoclonal Limits: Humans Language: English Journal: JAMA Year: 2021 Document Type: Article